What does Amantine do?
AMANTINE specializes in developing innovative solutions in the field of biotechnology. The company focuses on enhancing health and wellness through advanced research and development. With a commitment to sustainability, AMANTINE aims to create impactful products that address global health challenges.
- Sectors
- Consultancy firms
- Activities
- Signals
-
ProfitableProfitable € 593K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.32MStrong equity provides a buffer against setbacks.
Low riskLow risk 90.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.61A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 592KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 214KPositive EBITDA: operating activities are profitable.
- Investments
- Imeutex 99,97%, Avu 50%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
228K
|
€
253K
|
€
249K
|
€
193K
|
|
|
€
214K
|
€
251K
|
€
248K
|
€
191K
|
|
|
€
593K
|
€
505K
|
€
486K
|
€
413K
|
|
|
€
3.32M
|
€
3.51M
|
€
3.17M
|
€
2.91M
|
|
|
90.75%
|
87.35%
|
77.60%
|
78.37%
|
|
|
€
338K
|
€
508K
|
€
915K
|
€
803K
|
|
|
€
467K
|
€
738K
|
€
870K
|
€
497K
|
Publications 31
All publications- Kapitaal - Aandelen - Ontslagen - Benoemingen - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 11/09/2025
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 20/06/2025
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Ontslagen - Benoemingen 24/05/2022
- Ontslagen - Benoemingen 26/06/2019
- Me. - Jaarrekening 31.12.2015, Ggk 25.06.2016, Ngl 27.06.2016 16227-0014-013 01/07/2016
Frequently asked questions
Answers to the most common questions about Amantine, based on official government data and the filed annual accounts.
What is the VAT number of Amantine?
The VAT number of Amantine is BE0428.086.338.
When was Amantine established?
Amantine was founded in 29-11-1985.
What is the official address of Amantine?
The official address of Amantine is Klein-Mechelen(Bor) 75 Bornem 2880.
What is the legal form of Amantine?
The juridical form of Amantine is Public limited company (NV/SA).
What is the annual revenue of Amantine?
The 2025 accounts of Amantine do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Amantine do?
AMANTINE specializes in developing innovative solutions in the field of biotechnology. The company focuses on enhancing health and wellness through advanced research and development. With a commitment to sustainability, AMANTINE aims to create impactful products that address global health challenges.
Is Amantine a reliable company?
Amantine is a registered Rechtspersoon with company number 0428.086.338 and can be verified through the official CBE database.
What is the credit limit of Amantine?
The estimated credit limit of Amantine is €390,320.
Is Amantine still active?
Amantine currently has the status "Normal situation" and is active.